Patient Demographics and Tumor Response Are Assessed by MR Imaging in Previously Treated Liver Lobe 3 Months After 90Y Radioembolization
| RECIST 1.1 | |||
| Demographic | PR (n = 5) | Stable disease (n = 26) | PD (n = 17) |
| Age (y) | 59.6 ± 7.9 | 61.0 ± 12.5 | 58.8 ± 9.7 |
| Sex | |||
| Female (n) | 2 (4.2) | 10 (20.8) | 8 (16.7) |
| Male (n) | 3 (6.3) | 16 (33.3) | 9 (18.8) |
| Dose of 99mTc-MAA given (MBq) | 131.4 ± 31.1 | 152.6 ± 29.2 | 153.9 ± 30.9 |
| Liver-to-lung shunt (%) | 7.0 ± 2.4 | 5.9 ± 2.7 | 6.1 ± 2.4 |
| Dose of 90Y given (MBq) | 1,242.0 ± 181.2 | 1,179.2 ± 175.3 | 1,132.9 ± 278.3 |
| Low MAA | |||
| Group 1 | 0 | 4 (8.3) | 1 (2.1) |
| Group 2 | 0 | 9 (18.8) | 9 (18.8) |
| High MAA | |||
| Group 3 | 3 (6.3) | 9 (18.8) | 4 (8.3) |
| Group 4 | 2 (4.2) | 4 (8.3) | 3 (6.3) |
| Catheter position | |||
| Identical | 3 (6.3) | 14 (29.2) | 10 (20.8) |
| Different | 2 (4.2) | 12 (25.0) | 7 (14.6) |
Data are mean ± SD or n, with percentages in parentheses. Total number of patients was 48.